Chia‐Ron Yang

2.0k total citations
56 papers, 1.7k citations indexed

About

Chia‐Ron Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chia‐Ron Yang has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Immunology. Recurrent topics in Chia‐Ron Yang's work include Histone Deacetylase Inhibitors Research (17 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (6 papers). Chia‐Ron Yang is often cited by papers focused on Histone Deacetylase Inhibitors Research (17 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (6 papers). Chia‐Ron Yang collaborates with scholars based in Taiwan, United States and China. Chia‐Ron Yang's co-authors include Jing‐Ping Liou, Wan‐Wan Lin, Che‐Ming Teng, Shie-Liang Hsieh, Jyh‐Horng Wang, Feng‐Ming Ho, Hsueh‐Yun Lee, Yiwen Wu, Feng Ming Ho and Yook Chin Chia and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Chia‐Ron Yang

55 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chia‐Ron Yang Taiwan 25 1.0k 316 263 230 219 56 1.7k
Johannes Kreuzer United States 15 801 0.8× 277 0.9× 242 0.9× 188 0.8× 105 0.5× 25 1.5k
Carina L. Bos Netherlands 14 473 0.5× 212 0.7× 205 0.8× 141 0.6× 267 1.2× 17 1.4k
Chun‐Yin Huang Taiwan 30 1.2k 1.2× 463 1.5× 321 1.2× 411 1.8× 140 0.6× 60 2.2k
Allard Kaptein Netherlands 20 1.1k 1.1× 478 1.5× 422 1.6× 340 1.5× 144 0.7× 39 2.3k
Duncan H. Mak United States 33 1.6k 1.6× 428 1.4× 262 1.0× 223 1.0× 135 0.6× 88 2.5k
Caiping Chen China 21 782 0.8× 214 0.7× 161 0.6× 215 0.9× 130 0.6× 68 1.5k
Xin Wu China 19 793 0.8× 249 0.8× 232 0.9× 445 1.9× 114 0.5× 44 1.5k
Edward F. Webb United States 20 778 0.7× 267 0.8× 341 1.3× 163 0.7× 193 0.9× 36 1.7k
Daisuke Kamei Japan 20 720 0.7× 221 0.7× 198 0.8× 252 1.1× 829 3.8× 33 1.7k

Countries citing papers authored by Chia‐Ron Yang

Since Specialization
Citations

This map shows the geographic impact of Chia‐Ron Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Ron Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Ron Yang more than expected).

Fields of papers citing papers by Chia‐Ron Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Ron Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Ron Yang. The network helps show where Chia‐Ron Yang may publish in the future.

Co-authorship network of co-authors of Chia‐Ron Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Ron Yang. A scholar is included among the top collaborators of Chia‐Ron Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Ron Yang. Chia‐Ron Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Tony Eight, Wei‐Chun HuangFu, Jui‐Hua Hsieh, et al.. (2024). An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors. Protein Science. 33(6). e5007–e5007. 4 indexed citations
2.
Lai, Mei‐Jung, et al.. (2023). Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells. International Journal of Molecular Sciences. 24(16). 12588–12588. 6 indexed citations
3.
Sung, Ting‐Yi, Shiow‐Lin Pan, Wei‐Jan Huang, et al.. (2023). The study of a novel CDK8 inhibitor E966-0530–45418 that inhibits prostate cancer metastasis in vitro and in vivo. Biomedicine & Pharmacotherapy. 162. 114667–114667. 14 indexed citations
4.
Hsu, Kai‐Cheng, et al.. (2023). Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors. Biomedicine & Pharmacotherapy. 159. 114258–114258. 9 indexed citations
5.
Wu, Yiwen, Min‐Wu Chao, Huang‐Ju Tu, et al.. (2022). O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia. Phytomedicine. 100. 154061–154061. 7 indexed citations
6.
Yang, Chia‐Ron, et al.. (2022). Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways. European Journal of Pharmacology. 933. 175256–175256. 6 indexed citations
7.
Lin, Tony Eight, Chia‐Ron Yang, Min‐Wu Chao, et al.. (2021). Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment. Biomedicine & Pharmacotherapy. 146. 112459–112459. 15 indexed citations
8.
Yang, Chia‐Ron, et al.. (2019). 4-Substituted 2-amino-3,4-dihydroquinazolines with a 3-hairpin turn side chain as novel inhibitors of BACE-1. Bioorganic Chemistry. 95. 103135–103135. 11 indexed citations
9.
Sung, Ting-Yi, et al.. (2019). MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells. Frontiers in Oncology. 9. 249–249. 22 indexed citations
10.
Tu, Huang‐Ju, Min‐Wu Chao, Ting-Yi Sung, et al.. (2018). The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells. Clinical Epigenetics. 10(1). 162–162. 25 indexed citations
11.
Liou, Jing‐Ping, et al.. (2018). The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. Cell Death and Disease. 9(6). 655–655. 81 indexed citations
12.
13.
Chakraborty, Sharmistha, Chia‐Ron Yang, Kimmo J. Hatanpaa, et al.. (2013). An EGFR wild type–EGFRvIII–HB-EGF feed-forward loop regulates the activation of EGFRvIII. Oncogene. 33(33). 4253–4264. 35 indexed citations
14.
15.
Teng, Che‐Ming, et al.. (2010). Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways. The Journal of Nutritional Biochemistry. 22(8). 732–740. 19 indexed citations
16.
Yang, Chia‐Ron, Jih‐Hwa Guh, Che‐Ming Teng, Chih‐Cheng Chen, & PH Chen. (2009). Combined treatment with Denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC‐3 cells. British Journal of Pharmacology. 157(7). 1175–1185. 11 indexed citations
17.
Cheng, Chen‐Li, et al.. (2009). An HDAC inhibitor enhances the antitumor activity of a CMV promoter-driven DNA vaccine. Cancer Gene Therapy. 17(3). 203–211. 26 indexed citations
18.
Yang, Chia‐Ron & Robert K. Yu. (2008). Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. Journal of Neuroscience Research. 87(1). 26–33. 37 indexed citations
19.
Yang, Chia‐Ron, Shie-Liang Hsieh, Feng‐Ming Ho, & Wan‐Wan Lin. (2005). Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-κB-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression. The Journal of Immunology. 174(3). 1647–1656. 77 indexed citations
20.
Yang, Chia‐Ron, et al.. (2004). Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells. Cell Death and Differentiation. 11(S1). S97–S107. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Kreuzer Breakdown of academic impact, for papers by Carina L. Bos Breakdown of academic impact, for papers by Chun‐Yin Huang Breakdown of academic impact, for papers by Allard Kaptein Breakdown of academic impact, for papers by Duncan H. Mak Breakdown of academic impact, for papers by Caiping Chen Breakdown of academic impact, for papers by Xin Wu Breakdown of academic impact, for papers by Edward F. Webb Breakdown of academic impact, for papers by Daisuke Kamei
Rankless by CCL
2026